(Q33414453)

English

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

thrombocytopenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

3

object named as

Pierre Fenaux

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gianluca Gaidano

8

object named as

Gianluca Gaidano

2 references

Europe PubMed Central

PubMed publication ID

26 July 2017

ORCID Public Data File 2021

Aristoteles A N Giagounidis

1

object named as

Aristoteles Giagounidis

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Uwe Platzbecker

6

object named as

Uwe Platzbecker

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wieslaw Jedrzejczak

9

object named as

Wieslaw Wiktor-Jedrzejczak

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Ghulam J Mufti

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mikkael A Sekeres

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jeffrey Szer

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Andrea Kuendgen

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kuolung Hu

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Paul Woodard

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Allen S Yang

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hagop M Kantarjian

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

4 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

120

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1838-1846

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

Platelet function in the myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

14 July 2018

A prognostic score for patients with lower risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28663

21 January 2018

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28663

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28663

21 January 2018

Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4298760

31 October 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28663

21 January 2018

Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24706489

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/24706489

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28663

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28663

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33414453&oldid=2095825935"